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ABSTRACT
INTRODUCTION The aim of this study was to examine knowledge of 
health effects of smoking and the impact of cigarette package 
warnings among tobacco users from six European Union (EU) 
Member States (MS) immediately prior to the introduction 
of the EU Tobacco Products Directive (TPD) in 2016 and to 
explore the interrelationship between these two factors.
METHODS Cross-sectional data were collected via face-to-face 
interviews with adult smokers (n=6011) from six EU MS 
(Germany, Greece, Hungary, Poland, Romania, Spain) between 
June–September 2016. Sociodemographic variables and 
knowledge of health risks of smoking (KHR) were assessed. 
Warning salience, thoughts of harm, thoughts of quitting and 
foregoing of cigarettes as a result of health warnings were 
assessed. The Label Impact Index (LII) was used as a composite 
measure of warning effects. Linear and logistic regression analyses 
were used to examine sociodemographic predictors of KHR and 
LII and the inter-relationship between knowledge and LII scores.
RESULTS The KHR index was highest in Romania and Greece and 
lowest in Hungary and Germany. While the majority of smokers 
knew that smoking increases the risk for heart diseases, lung and 
throat cancer, there was lower awareness that tobacco use caused 
mouth cancer, pulmonary diseases, stroke, and there were very 
low levels of knowledge that it was also associated with impotence 
and blindness, in all six countries. Knowledge regarding the health 
risks of passive smoking was moderate in most countries. The LII 
was highest in Romania and Poland, followed by Spain and Greece, 
and lowest in Germany and Hungary. In almost all countries, there 
was a positive association between LII scores and higher KHR 
scores after controlling for sociodemographic variables. Several 
sociodemographic factors were associated with KHR and LII, with 
differences in these associations documented across countries.
CONCLUSIONS These data provide evidence to support the need for 
stronger educational efforts and policies that can enhance the 
effectiveness of health warnings in communicating health risks 
and promoting quit attempts. Data will serve as a baseline for 
examining the impact of the TPD.
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INTRODUCTION
The World Health Organization Framework 
Convention on Tobacco Control (WHO FCTC), 
an unprecedented international treaty aimed at 
strengthening tobacco control globally, underlines 
the importance of education, communication, training, 
and public awareness on the health risks of smoking1. 
A key aspect to educating the public on the deleterious 
effects of tobacco is the adoption of health warnings 
on cigarette packages1,2. Article 11 of the WHO FCTC 
addresses packaging and labeling of tobacco products 
by calling for ‘each unit packet and package of tobacco 
products, and any outside packaging and labeling of 
such products, to carry health warnings describing 
the harmful effects of tobacco use, and include 
other appropriate messages’1. With the exception 
of television advertisements, health warnings on 
cigarette packages are among the most effective 
sources of information regarding the health effects of 
smoking, with most smokers reporting becoming more 
aware about the risks of smoking through warnings 
on cigarette packages compared to other sources of 
information2. Evidence shows that combined written 
and graphic health messages are more effective than 
text-only warnings2-4. Pictorial warnings have been 
shown to increase levels of knowledge regarding 
the health effects of smoking, as well as increase 
motivation for smoking cessation behavior among 
smokers2-9.
The updated European Union (EU) Tobacco 
Products Directives (TPD), which took effect in May 
2016, is a major effort to propel and standardize the 
ratification of the WHO FCTC among EU Member 
States (MS), and has reinforced the importance 
of warning labels as an important tobacco control 
strategy since they are compelling communication 
strategy, combining high exposure, high reach, and 
very low cost10-12. In consideration of the strong 
evidence that health warnings increase awareness of 
health risks related to tobacco consumption, increase 
quit attempts and decrease smoking uptake and the 
realization of the disparities that exist among the 
EU MS in the implementation of the FCTC, the EU 
TPD has set forth rules governing the parameters of 
health warning labels that are scientifically supported 
to maximize impact. The TPD effectively requires 
combined text and pictorial health warnings that 
cover 65% of the front and back of tobacco product 
packaging10-12.
In many EU countries, full implementation of 
the 2016 TPD occurred in late fall of 2017. Prior 
to the TPD coming into effect, EU MS varied in 
the extent to which they had implemented text and 
pictorial warnings (Table 1). Moreover, the messages 
transmitted through health warnings varied across 
countries (Table 2).
In order to evaluate the impact of the TPD 
provisions on health warnings, it is necessary to 
establish a better understanding of the knowledge, 
perceptions, and behaviors related to heath warning 
labels among EU MS prior to the full implementation 
of such measures and establishment of a baseline 
for examining changes over time. This paper reports 
on knowledge of smoking health harms and the 
perceived impact of cigarette warning labels among 
smokers from six EU MS (Germany, Greece, Hungary, 
Poland, Romania, Spain) before the TPD exerted 
its full effects, and explores the interrelationship 
between these two factors as well sociodemographic 
variables. 
Table 1. Description of tobacco product warning labels in countries sampled in 20161 
Country Text warnings only
Medium (<50% of the front and back 
of package) pictorial warnings
Large (≥50% of the front and back of package) 
pictorial warnings
Germany X Introduced May 20162
Greece X
Hungary X Introduced August 20163
Poland X Introduced May 20162
Romania X
Spain X X4
1 Information refers to the data collection period (June–September 2016). 2 Introduced May 2016, but slow market penetration due to stockpiling. 3 Introduced on small 
quantity of packs in market. 4 Even though the TPD was not transposed in Spain at the time of the fieldwork, several manufacturers already sold packages according to the TPD 
requirements.
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METHODS
Study sample and methodology for data collection
The current study is part of a European Commission 
Horizon-2020 funded study entitled European 
Regulatory Science on Tobacco: Policy implementation 
to  r educe  lung  d i seases  (EUREST-PLUS-
HCO-06-2015). The EUREST-PLUS Project aims to 
monitor and evaluate the impact of the implementing 
Acts of the TPD within the context of the FCTC 
and its implementation within Europe13. Using the 
methodology of The International Tobacco Control 
Policy Evaluation (ITC) Project, a cross-sectional 
survey was conducted among six European countries 
(Wave 1 6E)14. A nationally representative sample of 
6011 cigarette smokers of age 18 years or older was 
collected from Germany (n=1003), Greece (n=1000), 
Hungary (n=1000), Poland (n=1006), Romania 
(n=1001), and Spain (n=1001). Ethics approval for 
data collection was provided for each national cohort 
by the corresponding local ethics committees and 
informed consent was received from all participants.
Data collection occurred between June 2016 and 
September 2016. According to Nomenclature of 
Territorial Units for Statistics (NUTS), the geographic 
strata were NUTS2 regions (NUTS1 in Germany) 
crossed with degree of urbanization (urban, semi-
urban, rural). Approximately 100 area clusters were 
sampled in each country, with the aim of obtaining 10 
adult smokers per cluster. Clusters were allocated to 
strata proportionally to the population size for adults 
18 years and older. Within each cluster, household 
addresses were sampled using a random walk design. 
One randomly selected male smoker and one randomly 
selected female smoker were chosen for interview 
from a sampled household where possible. Screening 
of households continued until the required number 
of smokers from the cluster had been interviewed. All 
interviews were conducted face-to-face by interviewers 
using tablets. Further details on the methodology of 
the 6E Survey can be found elsewhere13.
During the data collection period (June–Sept. 
2016), Greece had text warnings on tobacco packages, 
while Germany and Poland had just moved from 
text warnings to large pictorial warnings covering 
≥50% of the front and back of the package in May 
2016. Romania, Hungary and Spain had medium-
size pictorial warning (<50% of the front and back 
of package) which had been in place since 2008 
(Romania) or 2011 (Hungary and Spain); in Hungary 
since 20 August 2016, there may have been tobacco 
products with large pictorial warnings, but compared 
to all, probably only to a negligible extent (Table 1).
Table 2. Content of health warnings in 2016 by country and Tobaccco Product Directive (TPD)1
Health issue2 Germany Greece Spain Romania Hungary Poland TPD3,4
Active smoking
Heart disease Yes Yes Yes Yes Yes Yes Yes
Impotence Yes Yes Yes Yes Yes Yes Yes
Lung cancer Yes Yes Yes Yes Yes Yes Yes
Blindness No No No No No No Yes
Mouth cancer No No No No No No Yes
Throat cancer No No Implied5 Implied5 Implied5 No Yes
Stroke Yes Yes Yes Yes Yes Yes Yes
Emphysema Implied6 Implied7 Implied7 Implied7 Implied7 Implied6 Implied8
Bronchitis Implied6 Implied7 Implied7 Implied7 Implied7 Implied6 Implied8
Passive smoking
Lung cancer No Implied9 No No No No Implied10
Heart attacks No Implied9 No No No No Implied10
Asthma in children Implied11 Implied11 Implied12 Implied12 Implied12 Implied12 Implied10
1Information is provided for the content of the health warnings in June-September 2016 during the period of survey. 2 Information is provided for the content of the health 
warnings with regard to the issues included in the questions regarding the knowledge regarding health risks of smoking investigate by the survey. 3 TPD was in the process of 
introduction during the survey period in Germany, Hungary and Poland, but only of small quantities of packages were on the market. 4 In Spain, even though the TPD was not 
oficially in place, the TPD health warnings were already found on the packages of several brands on the market. 5 Smoking can cause a painful slow death, with a pictogram 
showing a tumour at the level of the throat. 6 Stopping smoking reduces the risk of serious heart and lung disease. 7 Quiting smoking decreases your risk for cardiovascular and 
pulmonary diseases. 8 Smoking damages your lungs. 9 Smoking seriously harms you and the ones around you. 10 Smoking harms your children, family and friends. 11 Protect 
children, do not force them to breathe in your smoke. 12 Protect your child, do not let them breathe your smoke. Smoking during pregnancy is bad for your child.
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Measures
Knowledge of health risks 
In order to assess knowledge of the health risks of 
smoking, respondents were presented with nine 
diseases and conditions (heart disease, impotence, 
lung cancer, blindness, mouth cancer, throat cancer, 
stroke, emphysema, bronchitis) and were asked to 
state whether they believed the condition is caused 
by smoking. Respondents were also asked to state if 
they believed secondhand smoke caused lung cancer 
in non-smokers, heart attacks in non-smokers, and 
asthma in children. Knowledge of health risks was 
coded as 0=‘not caused by smoking/don’t know’ 
and 1=‘caused by smoking’. An index regarding 
knowledge of the health risks of smoking (KHR) 
was calculated by summing the standardized scores 
(z-scores calculated across all countries) of each 
participant’s responses to the questions pertaining to 
health risks of smoking. 
Warning label impact
Warning label effects were measured using six 
indicators as in previous ITC surveys7,8,15-16. Each 
indicator was analyzed as a dichotomous measure 
of frequency. Warning label salience was assessed 
using two questions: 1) NOTICING: ‘in the last 
month, how often, if at all, have you noticed the 
warning labels on cigarette packages (1=very often 
or often; 0=sometimes, rarely, or never)?’, and 2) 
READING: ‘In the last month, how often, if at all, 
have you read or looked closely at the warning labels 
on cigarette packages (1=often; 0=never or once in 
a while)?’. THOUGHTS of harm were assessed with 
the following question: ‘to what extent, if at all, do 
the warning labels make you think about the health 
risks of smoking (1=a lot; 0=somewhat, a little, or not 
at all)?’. Thoughts of QUITTING were assessed with 
the question: ‘to what extent, if at all, do the warning 
labels on cigarette packs make you more likely to 
quit smoking (1=a lot; 0=somewhat, a little, or not 
at all)?’. FORGOING of cigarettes was assessed by 
asking: ‘in the last month, have the warning labels 
stopped you from having a cigarette when you were 
about to smoke one (1=many times, a few times, or 
once; 0=never)?’. AVOIDING was assessed: ‘in the last 
month, have you made any effort to avoid looking or 
thinking about the warning labels, such as covering 
them up, keeping them out of sight, using a cigarette 
case, avoiding certain warnings, or any other means 
(1=yes, 0=no)?’. 
The Labels Impact Index (LII) was calculated using 
the methodology employed in several previous ITC 
reports7,8,15-17. The LII is a composite measure that 
combines four of the six warning label effectiveness 
indicators and then weighting and summing the 
standardized scores (z scores) using the following 
calculation: LII = (NOTICING × 1) + (THOUGHTS 
× 2) + (QUITTING × 2) + (FORGOING × 3). The 
LII was calculated using the original four/five-point 
scales of the individual measures of health warning 
effectiveness, not dichotomized. Higher LII scores 
indicate greater impact16. 
Respondents were also asked if they would like to 
have more, less or the same amount of information 
contained in the health warnings.
Demographics and smoking behavior
Sociodemographic characteristics including country, 
age, gender, degree of urbanization (urban, semi-
urban, rural), level of education (low, medium, 
high) and income level (low, medium, high) were 
assessed. Highest level of formal education completed 
categorized as: low (primary, lower pre-vocational 
secondary, middle pre-vocational secondary), 
moderate (secondary vocational, senior general 
secondary and pre-university) and high (higher 
professional and university Bachelor, university 
Masters). Due to the different income cut-off points 
across countries, income was categorized as low, 
medium, and high using standardized country-level 
cut-offs established by the ITC Project18 as follows: 
low income level (<€1750 for Germany, Greece and 
Spain; ≤150000 Ft for Hungary; ≤2000 zł for Poland; 
≤1000 lei for Romania), moderate income (€1750 
to €3000; 150001 Ft to 250000 Ft; 2001 zł to 4000 
zł; 1001 lei to 2500 lei), and high income (>€3000, 
>250000 Ft, >4000 zł, >2500 lei). Smoking behavior 
included the assessment of number of cigarettes 
smoked per day (<10, 11–20, 21–30, >30). 
Statistical analyses
Data were analyzed with SPSS 20.0 using the Complex 
Samples package to account for the complex sampling 
design. We analyzed data for each country separately 
and calculated percentages and standard errors. All 
statistical estimates presented are weighted for sex, 
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2018;16(Suppl 2):A10
https://doi.org/10.18332/tid/99542     
5
age and degree of urbanization to make the data more 
representative of the population of smokers in each 
country. Participants who did not offer information 
regarding sociodemographic characteristics or the 
variables assessing the knowledge about health risks 
of smoking or the warning label impact were excluded 
from the analyses. Linear regression analyses were 
conducted to examine predictors of KHR and LII, 
the independent variables being age, gender, degree 
of urbanization, income, and education level, as well 
as the number of cigarettes smoked per day; these 
approaches were used based on previous relationships 
tested in other ITC studies4,8,15.
In order to assess if the label impact index influences 
knowledge regarding the health risks of smoking, two 
approaches were used. First, linear regressions were 
performed with the KHR index as the dependent 
variable and the LII index as the independent variable, 
controlling for sociodemographic variables, as well as 
the number of cigarettes smoked per day. Second, 
logistic regression was performed using as dependent 
variables the measures that assess the knowledge of 
the risk of smoking for several diseases, and using 
the LII index as the independent variable, controlling 
for age, gender, degree of urbanization, income, 
education level (sociodemographic variables) as well 
as the number of cigarettes smoked per day. 
RESULTS
Characteristics of the study sample
The study sample consisted of 6011 persons (47.2% 
women and 52.8% men; 35.4% were from urban areas, 
37.5% from semi-urban and 27.1% from rural areas). 
The mean age was 45.1 years (8.4%, 18–24 years; 
29.5%, 25–39; 33.3%, 40–54; 28.7% older than 54 
years). The education level was: 36.8% low, 51.6% 
medium, 11% high, 0.6% did not declare. With regard 
to the income, 22.2% had low income, 37.4% medium, 
17.4% high income, while 23% did not declare.
Knowledge of health risks (KHR) of smoking
With the exception of Hungary, more than 80% of the 
smokers in each country knew that active smoking 
causes heart diseases, lung cancer, and throat cancer 
(Table 3). More than two-thirds of smokers from all 
countries were aware of the risk of active smoking 
for pulmonary diseases (emphysema, bronchitis) and 
mouth cancer. In Spain and Hungary less than 60% of 
the smokers were aware of the risk of active smoking 
for stroke. The effect of smoking on impotence was 
recognized by approximately half of smokers and on 
blindness by one-third or less, the only exception 
being Romania where almost two-thirds knew the 
risk of smoking for impotence and more than half 
knew that smoking can cause blindness. Knowledge 
Table 3. Knowledge of the health risks (KHR) of smoking overall and by country (n=6011 )
Health Effect
Overall Germany Greece Spain Romania Hungary Poland
Per cent  who agreed (SE)
Active smoking
Heart disease 82.7 (1.0) 81.9 (2.8) 94.9 (1.1) 81.9 (2.5) 87.7 (1.6) 67.0 (3.1) 82.7 (2.6)
Impotence 56.1 (1.3) 50.2 (3.5) 61.7 (3.0) 53.7 (2.9) 64.3 (2.6) 54.7 (3.3) 52.0 (3.3)
Lung cancer 90.0 (0.7) 89.8 (2.6) 96.1 (0.8) 93.1 (1.8) 90.2 (1.2) 83.4 (1.9) 87.4 (1.9)
Blindness 34.7 (1.2) 23.8 (2.6) 33.0 (3.1) 24.4 (3.2) 57.6 (2.8) 35.7 (3.3) 33.9 (2.8)
Mouth cancer 78.0 (0.9) 71.3 (3.0) 85.3 (1.6) 84.7 (2.0) 76.7 (2.0) 70.7 (2.6) 79.3 (2.4)
Throat cancer 83.1 (0.9) 82.3 (2.8) 88.0 (1.4) 78.5 (2.3) 88.6 (1.3) 76.7 (2.3) 84.8 (2.2)
Stroke 65.2 (1.1) 71.5 (3.2) 68.6 (2.6) 56.4 (2.9) 78.1 (1.8) 55.6 (3.0) 61.0 (2.9)
Emphysema 72.5 (1.1) 68.7 (2.9) 78.6 (2.1) 75.2 (2.5) 66.2 (3.1) 69.1 (2.8) 77.2 (2.8)
Bronchitis 79.5 (1.0) 77.4 (2.7) 88.4 (1.7) 92.2 (1.7) 80.8 (1.7) 68.2 (3.0) 69.7 (3.0)
Secondhand smoke
Lung cancer 68.2 (1.2) 58.4 (3.4) 70.1 (3.1) 67.3 (3.6) 82.3 (1.7) 57.9 (3.2) 72.8 (2.7)
Heart attacks 56.3 (1.3) 41.1 (3.4) 63.2 (3.2) 51.3 (3.7) 73.4 (2.4) 43.5 (3.5) 65.1 (3.0)
Asthma in children 68.5 (1.2) 59.8 (3.6) 73.8 (2.8) 68.2 (2.7) 78.9 (2.0) 63.9 (3.2) 66.5 (2.8)
Mean (SE)
KHR Indexa -0.046 (0.220) -1.154 (0.662) 1.614 (0.371) -0.110 (0.514) 1.868 (0.435) -2.029 (0.610) 0.002 (0.583)
SE: standard error. a KHR Index, calculated using z scores. 
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regarding the health risks of passive smoking was 
moderate in most countries, with lower levels of 
knowledge documented in Germany and Hungary. 
The risks of passive smoking were best known by 
smokers in Romania (Table 3). Smokers from Hungary 
and Germany also reported the lowest KHR index 
score, while the highest scores were documented in 
Greece and Romania. 
The results of the regression analysis examining 
predictors or KHR are reported in Table 4. KHR 
index scores were lower among men than women 
in Germany, Hungary and Poland. In Romania 
and Greece, significantly lower KHR index scores 
were documented for smokers of age 18–24 years, 
Table 4. Predictors of knowledge of the health risks (KHR) of smoking index (results of linear regression analysis)
Variable
Germany Greece Spain Romania Hungary Poland
B ( 95% CI)
Age group
18–24 0.45 -2.72* 0.53 -3.29** -2.63 0.07
(-2.19, 3.08) (-5.24, -0.20) (-3.05, 4.12) (-5.35, -1.22) (-7.16, 1.90) (-2.76, 2.90)
25–39 0.57 -0.01 -0.205 -2.02** -1.08 -1.12
(-1.60, 2.74) (-1.03, 1.01) (-2.61, 2.20) (-3.45, -0.58) (-3.72, 1.55) (-3.24, 0.99)
40–54 1.37 0.06 0.88 0.59 -0.27 0.58
(-0.68, 3.42) (-1.15, 1.27) (-0.39, 2.15) (-0.68, 1.88) (-2.46, 1.92) (-1.11, 2.27)
> 54 Ref Ref Ref Ref Ref Ref
Gender
Male -1.59*** -0.49 0.19 -0.06 -1.64* -1.30*
(-2.50, -0.68) (-1.46, 0.48) (-1.49, 1.90) (-1.56, 1.45) (-3.01, -0.28) (-2.38, -0.22)
Female Ref Ref Ref Ref Ref Ref
Urbanization degree
Urban 0.50 0.19 -0.23 0.63 1.60 0.47
(-2.92, 3.93) (-2.12, 2.51) (-2.45, 2.40) (-1.39, 2.66) (-2.58, 5.79) (-2.30, 3.24)
Semi-urban 1.23 1.28 0.40 1.30 2.66 -1.280
(-1.30, 3.95) (-0.63, 3.19) (-2.13-2.93) (-1.10, 3.70) (-1.40, 6.73) (-4.04, 1.48)
Rural Ref Ref Ref Ref Ref Ref
Education
Low -2.18 -0.96 -1.60 -0.65 1.09 -1.32
(-5.1, 0.64) (-2.52, 0.59) (-3.70, 0.52) (-3.56, 2.25) (-3.43, 5.62) (-4.21, 1.57)
Medium -0.78 0.57 -1.38 -0.72 0.46 -0.258
(-2.94, 1.38) (-0.72, 1.86) (-3.28, 0.52) (-2.43, 0.98) (-4.07, 4.99) (-2.44, 1.93)
High Ref Ref Ref Ref Ref Ref
Income
Low -1.10 2.33 -1.72 0.36 -1.55 -0.35
(-3.49, 1.29) (-0.96, 4.75) (-3.80, 0.36) (-2.53, 3.25) (-4.21, 1.11) (-2.50, 1.81)
Medium -0.85 1.77 1.52 1.04 -1.00 -1.12
(-2.43, 0.74) (-0.32, 3.87) (-0.78, 3.84) (-0.86, 3.00) (-3.02, 1.02) (-3.08, 0.62)
High Ref Ref Ref Ref Ref Ref
Cigarettes/day
1–10 1.14 0.67 0.20 4.62 2.66 2.02
(-4.03, 6.17) (-1.09, 2.44) (-2.88, 3.29) (-1.08, 10.32) (-3.44, 8.76) (-1.96, 6.01)
11–20 -0.65 0.37 -0.09 3.32 1.93 2.68
(-4.05, 6.34) (-1.20, 1.94) (-3.01, 2.84) (-2.50, 9.14) (-4.19, 8.05) (-1.20, 6.56)
21–30 0.98 -0.73 -0.58 3.60 2.73 3.86*
(-4.26, 6.24) (-2.67, 1.20) (-4.01, 2.84) (-2.27, 9.48) (-4.17, 9.65) (0.22, 7.71)
>30 Ref Ref Ref Ref Ref Ref
Missing cases were excluded from the analysis. Ref: indicates the reference group in the linear regression analyses. *p<0.05, **p<0.01, ***p<0.001.
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compared to older age groups. In Poland, smokers 
who smoke less cigarettes/day had a better score. No 
other significant associations were documented for 
income or education at the country-level. 
Effects of warning labels
The proportion of smokers who reported noticing 
warning labels ‘often or very often’ varied across 
countries (Table 5). Specifically, rates were lowest 
in Greece and Hungary, and highest in Romania and 
Poland where more than half of respondents reported 
they noticed the warnings. Less than one in five 
smokers declared that they read the warning labels 
often or very often, except in Romania where one-
third of the smokers declared this. 
The percentage of smokers who recalled seeing 
a helpline number on cigarette packs was around 
30% in Germany, Romania and Poland, but was lower 
than 22% in Hungary and Spain, while in Greece 
it was around 7%. Information regarding quitting 
websites was noticed on cigarette packs by about 
15% of smokers in all countries, ranging from the 
highest in Germany (20.9%) to the lowest in Greece 
(5.4%). 
The percentage of smokers who declared that 
the warning labels made them think ‘a lot’ about 
health risks or made them more likely to quit was 
less than 6% for all countries, except in Romania, 
where more than 10% declared this. In Germany, 
Greece, Spain and Romania, 15% or less of smokers 
declared that in the last 30 days warning labels 
made them refrain from smoking at least once, 
while the percentage in Hungary and Poland was 
around 20%.
LII scores were lowest in Germany and Hungary, 
followed by Greece and Spain, and highest in Poland 
and Romania (Table 5). In all countries, except for 
Spain, the LII was higher among respondents who 
reported lower daily cigarette consumption (Table 6). 
In Poland, the LII was lower among people with 
lower educational level, while in Romania it was 
higher among those with low income. In Poland and 
Romania, it was lower among younger age groups, 
while in Greece a reverse situation was found. In 
Germany, urban residence was positively associated 
with a higher LII, while in Poland, the LII was lower 
among men.
Around two-thirds of smokers reported they wanted 
the same amount of health information to appear on 
cigarette packages, with the exception of Germany 
where more than 40% of smokers reported wanting 
less information on warning labels.
Table 5. Effects of warning labels and Label Impact Index (LII) scores overall and by country (n=6011 )
Variable
Overall Germany Greece Spain Romania Hungary Poland
% (SE) % (SE) % (SE) % (SE) % (SE) % (SE) % (SE)
Noticing 38.3 (1.1) 30.7 (2.7) 21.4 (2.4) 36.6 (3.0) 56.5 (2.8) 25.2 (2.6) 59.2 (2.9)
Reading 20.2 (0.9) 11.5 (1.5) 21.9 (2.5) 12.6 (1.2) 37.6 (2.9) 15.0 (2.3) 20.7 (2.4)
Thoughts 5.6 (0.4) 4.7 (1.2) 5.1 (1.0) 5.1 (1.0) 12.8 (1.3) 3.0 (0.8) 3.3 (0.9)
Quitting 4.0 (0.4) 3.2 (0.9) 2.5 (0.7) 2.4 (0.6) 10.6 (1.3) 1.4 (0.5) 3.9 (1.0)
Foregoing 15.4 (0.8) 10.3 (1.5) 13.5 (1.7) 14.2 (2.2) 14.5 (1.7) 18.3 (2.3) 21.6 (2.6)
Avoidance 13.3 (0.7) 9.9 (1.4) 14.2 (1.6) 19.9 (1.9) 16.5 (2.0) 9.2 (1.8) 10.4 (1.6)
Saw quitting supports 
Helpline numberb 24.0 (1.0) 28.6 (2.3) 6.5 (1.3) 19.2 (2.4) 36.3 (2.6) 21.8 (3.0) 31.4 (2.4)
Quitting websiteb 15.2 (0.8) 20.9 (2.1) 5.4 (1.1) 15.7 (1.7) 17.9 (1.9) 14.8 (2.3) 16.4 (1.9)
Health Information
Want more 14.4 (0.7) 8.4 (1.3) 23.5 (2.1) 14.9 (1.7) 25.1 (2.2) 3.0 (0.6) 11.9 (1.3)
Want the same 63.1 (1.1) 46.5 (3.0) 63.8 (2.7) 61.2 (2.3) 60.6 (2.7) 72.2 (2.7) 74.3 (2.1)
Want less 18.3 (0.9) 40.0 (3.0) 10.9 (1.7) 18.8 (2.0) 11.1 (1.3) 21.9 (2.5) 7.3 (1.4)
Mean Score (SE)
Label Impact Index (LII) -0.071 (0.147) -1.090 (0.327) -0.335 (0.364) -0.378 (0.318) 1.519 (0.343) -0.650 (0.378) 0.507 (0.422)
Label Impact Index (LII) is a composite measure that weights and standardizes scores for four of the six label effects indicators based on non-dichotomized data (i.e. original 
four/five-point scales). LII = (NOTICING × 1) + (THOUGHTS × 2) + (QUITTING × 2) + (FORGOING × 3). Higher scores indicate greater impact.
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Relationship between the level of knowledge and 
labels impact index
Table 7 shows that in all countries, except 
for Poland, a higher LII score was positively 
associated with a higher KHR index score, even 
after controlling for sociodemographic variables 
and number of cigarettes smoked per day. Higher 
LII scores were also associated with greater 
knowledge of specific smoking-related diseases 
and conditions. 
Table 6. Predictors of the Label Impact Index (LII) (results of linear regression analysis)
Variable
Germany Greece Spain Romania Hungary Poland
B ( 95% CI)
Age group
18–24 1.11 -0.20 1.01 -2.27** -1.08 0.07
(-0.29, 2.52) (-1.88,1.49) (-1.44, 3.45) (-3.69, -0.84) (-3.45,1.28) (-2.28, 2.42)
25–39 0.50 1.52* -1.09 -0.82 1.14 -1.31*
(-0.58, 1.58) (0.27, 2.78) (-2.47, 0.30) (-2.25, 0.61) (-0.30, 2.59) (-2.34, -0.27)
40–54 0.40 1.30 -0.05 0.46 -0.26 -0.41
(-0.44, 1.24) (-0.09, 2.70) (1.66, 1.56) (-0.90, 1.82) (-1.61, 1.09) (-1.68, 0.85)
> 54 Ref Ref Ref Ref Ref Ref
Gender
Male -0.57 -0.02 -0.91 -0.64 -0.61 -1.19**
(-1.20, 0.06) (-0.83, 0.80) (-1.88, 0.06) (-1.67, 0.40) (-1.35, 0.14) (-1.95, -0.43)
Female Ref Ref Ref Ref Ref Ref
Urbanization degree
Urban 1.66* -1.13 -0.51 -0.73 0.11 0.97
(0.16, 3.17) (-3.57, 1.32) (-3.14, 2.13) (-2.13, 0.67) (-1.95, 2.17) (-0.93, 2.88)
Semi-urban 0.23 -0.25 0.46 0.05 -0.310 0.34
(-1.08-1.54) (-2.06, 1.55) (-2.11, 3.03) (-1.71, 1.81) (-2.26, 1.64) (-1.68, 2.36)
Rural Ref Ref Ref Ref Ref Ref
Education
Low -1.17 -1.05 -0.38 -0.88 -1.45 -1.97*
(-2.90, 0.57) (-2.53, 0.42) (2.46, 1.70) (-2.63, 0.88) (-4.27, 1.36) (-3.91, -0.03)
Medium -1.19 -0.30 0.38 -0.31 -1.36 0.71
(-3.16, 0.79) (-1.58, 0.98) (-1.59, 2.34) (-1.82, 1.20) (-4.26, 1.52) (-0.87, 2.29)
High Ref Ref Ref Ref Ref Ref
Income
Low -0.05 0.94 0.74 1.68* 0.87 -0.01
(-1.28, 1.18) (-0.50, 2.39) (-1.04, 2.52) (0.18, 3.18) (-0.76, 2.50) (-1.88, 1.87)
Medium -0.05 1.29 1.41 0.86 1.22 -0.17
(-0.94, 0.84) (-0.07, 2.66) (-0.28, 3.10) (-0.27, 2.00) (-0.21, 2.66) (-1.50,1.17)
High Ref Ref Ref Ref Ref Ref
Cigarettes/day
1–10 2.90** 1.83** 1.80 2.97* 4.27** 2.91**
(1.14, 4.65) (0.49, 3.18) (-0.16, 3.75) (0.03, 5.92) (1.78, 6.75) (1.19, 4.63)
11–20 1.46 0.93 0.95 1.01 2.28 2.76**
(-0.05, 2.97) (-0.18, 2.04) (-0.88, 2.79) (-1.67, 3.70) (-0.27, 4.58) (1.17, 4.35)
21–30 0.92 0.24 0.32 -0.39 1.26 1.49
(-0.70, 2.55) (-1.47, 1.94) (-1.77, 2.40) (-3.25, 2.49) (-1.89, 4.43) (-0.63, 3.60)
>30 Ref Ref Ref Ref Ref Ref
Missing cases were excluded from the analysis. Ref: indicates the reference group in the linear regression analyses. *p<0.05; **p<0.01; ***p<0.001. 
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The findings of this study indicate that there are 
significant gaps in smokers’ understanding of the 
health risks of smoking across the six EU MS of the 
EUREST-PLUS ITC Survey. The vast majority of 
smokers were aware that smoking causes illnesses 
such as heart disease, lung and throat cancers. 
However, more than 20% of the smokers did not know 
that tobacco use causes mouth cancer, pulmonary 
diseases, and stroke. Smokers’ knowledge of the 
causal relationship between smoking and impotence 
and blindness was significantly lower. Importantly, 
with the exception of Romania, modest levels of 
knowledge of the health harms caused by exposure 
to secondhand smoke were observed across all six 
EU MS. These findings are similar to that of previous 
ITC reports for other countries4,19-21. All countries in 
the present study included health warning labels that 
address risk of heart attack, stroke, lung cancer, and 
impotence, and to a lesser extent messages regarding 
blindness, throat, or mouth cancers. Warning labels 
included non-specific or general messages in terms 
of lung disease but did not include specific messages 
related to emphysema or bronchitis. For the most part, 
warning labels did not include specific messages about 
Table 7. Relationship between knowledge of health effects (KHR index as well as specific knowledge about 
several health risks) and label impact index (LII) 
Variable
Germany Greece Spain Romania Hungary Poland
B ( 95% CI)a
KHR Index 0.33*** 0. 15** 0.29*** 0.30*** 0.30*** 0.14
(0.18, 0.49) (0.04, 0.25) (0.16, 0.42) (0.20, 0.40) (0.13, 0.46) (-0.03, 0.30)
Health Effect Adjusted OR ( 95% CI)b
Active smoking
Heart disease 1.10*** 1.02 1.16*** 1.16*** 1.05* 0.99
(1.04, 1.15) (0.96, 1.09) (1.07, 1.26) (1.08, 1.23) (1.01, 1.11) (0.93, 1.07)
Impotence 1.08** 1.05* 1.08** 1.07*** 1.06** 1.06**
(1.03, 1.12) (1.01, 1.09) (1.02, 1.14) (1.04, 1.10) (1.02, 1.10) (1.01, 1.11)
Lung cancer 1.10* 1.21* 1.07 1.08 1.00 1.00
(1.01, 1.18) (1.03, 1.41) (0.97, 1.18) (1.00, 1.17) (0.92, 1.05) (0.93, 1.05)
Blindness 1.09*** 1.02 1.07*** 1.07*** 1.07** 1.08***
(1.04, 1.14) (0.99, 1.06) (1.04, 1.12) (1.04, 1.11) (1.02, 1.11) (1.05, 1.11)
Mouth cancer 1.08* 1.05 1.14** 1.10*** 1.02 1.02
(1.02, 1.14) (1.00, 1.11) (1.06, 1.23) (1.05, 1.16) (0.98, 1.07) (0.97, 1.08)
Throat cancer 1.11** 1.05 1.08** 1.09** 1.03 0.99
(1.05, 1.18) (1.00, 1.13) (1.02, 1.14) (1.03, 1.16) (0.98, 1.08) (0.95, 1.05)
Stroke 1.06* 1.04 1.06** 1.11*** 1.05* 1.02
(1.01, 1.11) (0.99, 1.09) (1.01, 1.10) (1.07, 1.15) (1.01, 1.09) (0.97, 1.06)
Emphysema 1.05 0.97 1.03 1.07*** 1.05* 1.00
(0.99, 1.09) (0.91, 1.02) (0.98, 1.09) (1.04, 1.11) (1.01, 1.09) (0.95, 1.05)
Bronchitis 1.03 0.99 1.07 1.11*** 1.04 1.05
(0.97, 1.09) (0.95, 1.05) (0.98, 1.19) (1.06, 1.16) (0.99, 1.09) (1.00, 1.10)
Secondhand smoke
Lung cancer 1.06* 1.04 1.07** 1.05* 1.05* 1.04
(1.02, 1.11) (0.99 -1.09) (1.01, 1.12) (1.01, 1.09) (1.01, 1.09) (1.00, 1.09)
Heart attacks 1.07** 1.04 1.06* 1.07*** 1.06** 1.06**
(1.03, 1.12) (0.99, 1.08) (1.01,1.11) (1.04,1.12) (1.02, 1.10) (1.01, 1.10)
Asthma in children 1.08** 1.05* 1.07* 1.10*** 1.03 1.03
(1.03, 1.13) (1.10, 1.11) (1.02, 1.13) (1.06, 1.14) (0.99, 1.07) (0.99, 1.08)
Missing cases were excluded from the analysis. a Linear regression analysis adjusted for age, gender, urbanization degree, income, education level, and cigarettes smoked/day.
b Multiple logistic regression analysis adjusted for age, gender, urbanization degree, income, education level, and cigarettes smoked/day. *p<0.05, **p<0.01, ***p<0.001.
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health effects of secondhand smoke on heart disease 
and lung cancer or asthma in children. In general, 
levels of knowledge observed in countries for specific 
diseases and conditions corresponded to the specific 
warning labels’ messages in circulation. 
There were several country-level differences 
documented, with Romania and Greece having a 
greater percentage of smokers who recognized the 
smoking health harms for most of the diseases/
conditions assessed and higher scores on the 
KHR index. The lowest KHR index scores were 
documented in Germany and Hungary. These trends 
did not necessarily correspond to strong health 
warning labels in these countries in 2016. Given that 
there are other sources of information on the health 
risks of smoking, including educational programs in 
schools, mass media, and medical advice, the higher 
rates of KHR scores documented in some countries 
are potentially the consequence of several activities, 
in addition to warning labels, however this requires 
further validation22-24. For instance, EUREST-PLUS 
Project findings show that there is an association 
between high exposure to mass media anti-smoking 
campaigns and increased knowledge of smoking 
health harms25. Moreover, in Hungary, despite the 
fact that pictorial warnings were used on tobacco 
packages, many smokers were using roll-your-own 
(RYO) tobacco, and packaging of RYO rolling papers 
and filters, which had no health warning information 
prior to August 201626.
Several sociodemographic factors were associated 
with KHR index scores although trends varied 
between countries sampled. In three countries 
(Germany, Hungary, Poland) women had higher KHR 
scores, while in Romania and Greece, older age was 
associated with better KHR scores. 
Our study found that only about one-third of 
smokers noticed warning labels often or very 
often, and only 20% read them often or very often. 
Approximately 5% of smokers declared that the 
warning labels made them think ‘a lot’ about health 
risks, or made them more likely to quit, and 15% 
reported warning labels made them refrain from 
smoking at least once. Seeing quitline and website 
information was reported at significantly lower rates 
in Greece, which is expected given this information 
did not appear on the warning labels in Greece in 
2016 due to the non-existence of a National quitline. 
Additionally, there was variability between countries 
with regard to health warnings’ impact on perceptions 
and actions of the smokers. For instance, Romania 
and Poland were the countries with the highest LII 
scores, while Germany and Hungary had the lowest 
scores. One potential explanation of the low LII score 
observed in Hungary could be that almost half of 
smokers in Hungary reported using roll-your-own 
(RYO) tobacco, while packaging of RYO rolling papers 
and filters had no health warning information prior 
to August 201626. At the same time, the impact might 
vary between countries also as a consequence of type 
(only text or text and pictorials) and dimension of the 
health warning, and the type of messages2-9.
There was a correlation between higher daily 
cigarette consumption and lower LII scores. Other 
socioeconomic characteristics also influenced the LII 
at the country level. In Poland and Romania, the LII 
was higher among older age groups, while in Greece 
a reverse situation was observed. In Germany, urban 
residence was positively associated with a higher LII, 
while in Poland, the LII was higher among smokers 
with higher educational level. Other country-level 
factors, including the prevalence of tobacco use, 
characteristics of tobacco users and the extent to 
which comprehensive tobacco policies have been 
implemented are also expected to play a role in 
warning label effectiveness. As has been reported by 
others, it is possible that cultural factors, including 
receptivity to regulation, may play a role in explaining 
part of the differences observed between countries27,28.
In almost all countries, a significant positive 
relationship was documented between a KHR and LII 
scores. Romania and Germany being the countries 
where this relationship was evident for 10 or 11 of 
the 12 investigated health risks, while in the other 
countries the LII scores were associated with the level 
of knowledge for at least three health risks.
Implications to practice 
These data provide evidence to support the need for 
stronger education and policies that can enhance 
the effectiveness of health warnings among EU MS. 
Previous ITC studies showed that health warnings 
on cigarette packages are an important source of 
information regarding health effects of smoking8,10. 
A recent systematic review showed that stronger 
warnings increased attention to warnings, recall of 
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warnings, and thinking about the health risks of 
smoking, as well as perceptions that warnings reduce 
smoking and motivate quitting27. There is substantial 
evidence to suggest that strengthening health 
warnings, such as those outlined in the EU TPD, 
will increase the effectiveness of warning labels and 
address some of the gaps in knowledge and salience, 
as well as promote quitting-related behaviors2,3,5,27. 
The documented gaps in knowledge regarding the 
health effects of secondhand smoke may also be an 
important target for public awareness in countries 
that are still struggling with implementation of 
comprehensive smoke-free public spaces, cars, and 
homes. 
Importantly, this study serves as a baseline for 
examining the impact of the TPD, which began its 
implementation in most countries examined in the 
EUREST-PLUS ITC Wave 1 Survey in 2016. Future 
longitudinal studies should investigate changes in 
knowledge regarding health risks of smoking and 
the effectiveness of warning labels over time and as 
a consequence of implementing the TPD in the EU, 
which will be done within the context of this Horizon 
2020 project.
Limitations and strengths
While this study has many strengths with a large 
sample size of smokers across six nationally 
representative EU MS, findings should be interpreted 
in light of study limitations. First, the study used 
a cross-sectional design, which allows for the 
exploration of association rather than causality. The 
study included only current smokers and as such does 
not reflect individuals who recently quit smoking. The 
results are also based on participant self-report that 
may be subject to respondent and measurement bias. 
The present study examined variables prior to the 
implementation of the EU TPD and in some countries 
large pictorial warnings had been introduced just 
prior to our assessment and may not be sufficient to 
measure the effects of warning label changes in these 
countries. Likewise, KHR may have been influenced 
by other sources of education including mass media, 
which were not examined as part of this study. Given 
that the above warnings differed across countries 
including the size and health effects featured, some 
country level differences would be expected that were 
not controlled for in the analysis. In addition, there are 
other individual-level factors (e.g. nicotine addiction, 
presence of smoking-related illness or mental health 
illness) that might influence outcomes of interest that 
were not examined as part of this study. 
Nevertheless, this study is the only one of its kind 
to provide a comprehensive baseline of the impact 
of health warning labels on smokers’ knowledge and 
smoking behaviors across multiple EU MS prior to 
the full implementation of the EU TPD, which will 
then be used to evaluate the impact of health warning 
provisions in a post-TPD assessment. 
CONCLUSIONS
This study has documented important gaps in EU 
smokers’ knowledge of the health effects of active 
and secondhand smoke and the impact of health 
warning labels prior to implementation of the EU 
TPD. These data provide evidence to support the need 
for stronger education and policies that can enhance 
the effectiveness of health warnings among EU MS, 
and will serve as a baseline for examining changes in 
these indicators following implementation of the TPD. 
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